Inventor · disambiguated record
Khehyong Ngu
Also filed as: NGU KHEHYONG
20 granted patents·9 pending applications·180 citations·filing 1997–2024
94Inventor score
Top patents by PatentIndex Score
29 records- 0193US7745447B2Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 29, 2010·28 cites·1 claims
- 0293US7326705B2Heterocyclic sodium/proton exchange inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 5, 2008·24 cites·18 claims
- 0392US6887870B1Heterocyclic sodium/proton exchange inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 3, 2005·51 cites·28 claims
- 0485US11524959B1Indole and azaindole inhibitors of pad enzymesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 13, 2022·3 cites·18 claims
- 0585US8012984B2Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methodsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Sep 6, 2011·7 cites·24 claims
- 0684US2023192645A1Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0781US8067420B2Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methodsSTEIN PHILIP D·Filed 2011·Granted Nov 29, 2011·7 cites·17 claims
- 0879US7371759B2HMG-CoA reductase inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 13, 2008·11 cites·20 claims
- 0977US7238702B2Dihydroquinazolinones as 5HT modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jul 3, 2007·3 cites·8 claims
- 1076US11623921B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 11, 2023·0 cites·7 claims
- 1175US6281245B1Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereofVERSICOR INC·Filed 1998·Granted Aug 28, 2001·28 cites·27 claims
- 1273US10604504B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 31, 2020·0 cites·14 claims
- 1372US2020165222A1Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1469US10329274B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 25, 2019·0 cites·14 claims
- 1568US10865191B2Heterocyclic compounds useful as modulators of TNF alphaBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 15, 2020·1 cites·4 claims
- 1667US2025145590A1Ubiquitin specific processing protease 1 (usp1) compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1764US2024199584A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1861US8563583B2Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonistsAHMAD SALEEM·Filed 2010·Granted Oct 22, 2013·1 cites·21 claims
- 1961US2009011994A1Non-basic melanin concentrating hormone receptor-1 antagonists and methodsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 2058US7432271B2Pyrazolyl inhibitors of 15-lipoxygenaseBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 7, 2008·1 cites·4 claims
- 2158US2024217982A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2258US2024317769A1Kras g12d inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2355US6448058B1Methods for solid phase synthesis of mercapto compounds and derivatives, combinatorial libraries thereof and compositions obtained therebyVERSICOR INC·Filed 1998·Granted Sep 10, 2002·10 cites·3 claims
- 2454US6541276B2Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereofVERSICOR INC·Filed 1997·Granted Apr 1, 2003·5 cites·7 claims
- 2550US12492202B2Macrocyclic PAD4 inhibitors useful as immunosuppressantBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 9, 2025·0 cites·21 claims
- 2646US2022348562A1Benzimidazole inhibitors of pad enzymesBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2745US7317032B2Imidazolyl inhibitors of 15-lipoxygenaseBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jan 8, 2008·0 cites·4 claims
- 2843US2022402950A1Substituted benzimidazoles as pad4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2938US9062028B2Bicyclic nitrogen containing heteroaryl TGR5 receptor modulatorsROBL JEFFREY A·Filed 2012·Granted Jun 23, 2015·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →